Rare Disease Day - Clinical Gene Therapy: The Future is Now

Rare Disease Day is an annual observance to raise awareness for diseases that otherwise would not receive the recognition that they deserve. The day serves to improve access to medical treatments and research for patients and their families.

wilsonThis year's program, Clinical Gene Therapy: The Future is Now, will feature a poster session followed by a panel of patients and a clinician.

James M. Wilson, MD, PhDDirector of the Orphan Disease Center at the University of Pennsylvania will serve as this year's keynote speaker.

Research Poster Abstract Submission

Research poster abstract submissions will be accepted on basic, translational, and clinical research related to rare diseases and their treatments.

RSVP and Abstract Submission

Date/time:

Friday, March 1st, 2019
11:00am to 2:30pm

Location:

Graduate Hotel, Minneapolis, MN

Agenda

9:00-10:00
Patient Advocacy Group Breakfast

10:30-12:00
Poster Session
Research posters related to rare diseases or orphan drug research from investigators and their trainees

11:45 
Lunch

12:00-2:00 
Program

2:00-2:30
Networking

Co-Sponsors of Rare Disease Day

University of Minnesota Medical School, Stem Cell Institute
Center of Orphan Drug Research

Accreditation

ja logoIn support of improving patient care, University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Medical Association (AMA)

This activity has been approved for AMA PRA Category 1 Credit™. Determination of exact number of credits is pending.

Accreditation Council for Pharmacy Education (ACPE)

This activity is eligible for ACPE credit; see final CPE activity announcement for specific details.

Other Healthcare Professionals

Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”